Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn

NCT02261883 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

42

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Persistent Pulmonary Hypertension of the Newborn

Interventions

DRUG: IV Remodulin
DRUG: Placebo

Sponsor

United Therapeutics